BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8427754)

  • 1. Clot formation in angiographic catheters--an in vitro comparative study. Effects of heparin and protein coating of the catheter.
    Raininko R; Söder H
    Acta Radiol; 1993 Jan; 34(1):78-82. PubMed ID: 8427754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood clot formation in angiographic catheters. In vitro tests with various contrast media.
    Raininko R; Riihelä M
    Acta Radiol; 1990 Mar; 31(2):217-20. PubMed ID: 2372468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombogenicity of hydrophilically coated guide wires and catheters.
    Leach KR; Kurisu Y; Carlson JE; Repa I; Epstein DH; Urness M; Sahatjian R; Hunter DW; Casteneda-Zuniga WR; Amplatz K
    Radiology; 1990 Jun; 175(3):675-7. PubMed ID: 2343111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Anthron, an antithrombogenic coating for angiographic catheters.
    Nagaoka S; Noishiki Y
    J Biomater Appl; 1989 Jul; 4(1):3-21. PubMed ID: 2746467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-coated angiographic catheters: an in vivo comparison of three coating methods with different heparin release profiles.
    Lee KH; Han JK; Byun Y; Moon HT; Yoon CJ; Kim SJ; Choi BI
    Cardiovasc Intervent Radiol; 2004; 27(5):507-11. PubMed ID: 15383856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of antithrombogenicity of a new heparinized hydrophilic polymer: chronic in vivo studies and clinical application.
    Idezuki Y; Watanabe H; Hagiwara M; Kanasugi K; Mori Y
    Trans Am Soc Artif Intern Organs; 1975; 21():436-49. PubMed ID: 1146018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of umbilical artery catheter clots with heparinized infusates.
    David RJ; Merten DF; Anderson JC; Gross S
    Dev Pharmacol Ther; 1981; 2(2):117-26. PubMed ID: 7472106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein adsorption on polyurethane catheters modified with a novel antithrombin-heparin covalent complex.
    Du YJ; Brash JL; McClung G; Berry LR; Klement P; Chan AK
    J Biomed Mater Res A; 2007 Jan; 80(1):216-25. PubMed ID: 17072855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catheter coatings, blood flow, and biocompatibility.
    Eberhart RC; Clagett CP
    Semin Hematol; 1991 Oct; 28(4 Suppl 7):42-8; discussion 66-8. PubMed ID: 1822610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo rabbit acute model tests of polyurethane catheters coated with a novel antithrombin-heparin covalent complex.
    Du YJ; Klement P; Berry LR; Tressel P; Chan AK
    Thromb Haemost; 2005 Aug; 94(2):366-72. PubMed ID: 16113827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombogenicity of heparin- and non-heparin-coated catheters: clinical trail.
    Kido DK; Paulin S; Alenghat JA; Waternaux C; Riley WD
    AJR Am J Roentgenol; 1982 Nov; 139(5):957-61. PubMed ID: 6751056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzalkonium-heparin-coated angiographic catheters. Experience with 563 patients.
    Hawkins IF; Kelley MJ
    Radiology; 1973 Dec; 109(3):589-91. PubMed ID: 4772171
    [No Abstract]   [Full Text] [Related]  

  • 13. Thrombus formation at the surface of guide-wire models: effects of heparin-releasing or heparin-exposing surface coatings.
    Aldenhoff YB; Hanssen JH; Knetsch ML; Koole LH
    J Vasc Interv Radiol; 2007 Mar; 18(3):419-25. PubMed ID: 17377189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH--an in vitro study.
    Unger JK; Haltern C; Portz B; Dohmen B; Gressner A; Rossaint R
    Nephrol Dial Transplant; 2006 Aug; 21(8):2191-201. PubMed ID: 16567341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombosis of angiographic catheters in humans: experimental study.
    Bailly AL; Lautier A; Laurent A; Guiffant G; Dufaux J; Houdart E; Labarre D; Merland JJ
    Int J Artif Organs; 1999 Oct; 22(10):690-700. PubMed ID: 10585134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discard volumes necessary for clinically useful coagulation studies from heparinized Hickman catheters.
    Mayo DJ; Dimond EP; Kramer W; Horne MK
    Oncol Nurs Forum; 1996 May; 23(4):671-5. PubMed ID: 8735325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A scanning electron microscopic study on thrombogenicity of intraarterial catheters for chemotherapeutic treatment in head and neck cancer.
    Moser D; Rasse M; Schopper C; Lagogiannis G; Frass M; Ewers R; Kaye AD; Hofbauer R
    Head Neck; 2002 Jun; 24(6):566-74. PubMed ID: 12112554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of a heparin-poly(vinyl alcohol) hydrogel coating.
    Goosen MF; Sefton MV
    J Biomed Mater Res; 1983 Mar; 17(2):359-73. PubMed ID: 6841373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique.
    Sperling C; Houska M; Brynda E; Streller U; Werner C
    J Biomed Mater Res A; 2006 Mar; 76(4):681-9. PubMed ID: 16302224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and systemic heparinization in diagnostic and interventional neuroradiology.
    Debrun GM; Viñuela FV; Fox AJ
    AJR Am J Roentgenol; 1982 Jul; 139(1):139-42. PubMed ID: 6979849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.